Renaissance Technologies (RenTech)'s VHT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 13,560 shares of Vanguard Health Care ETF (VHT) worth $3.9 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VHT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 10,300 shares. Largest reduction occurred in Q2 2023, reducing 7,700 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Vanguard Health Care ETF (VHT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanguard Health Care ETF (VHT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +8,160 | Add 151.11% | 13,560 | $287.85 |
| Q3 2025 | -4,900 | Reduce 47.57% | 5,400 | $259.60 |
| Q2 2025 | +10,300 | New Buy | 10,300 | $248.34 |
| Q1 2025 | -2,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | -800 | Reduce 24.24% | 2,500 | $253.69 |
| Q3 2024 | +3,300 | New Buy | 3,300 | $282.20 |
| Q2 2024 | -3,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | +3,700 | New Buy | 3,700 | $270.54 |
| Q3 2023 | -900 | Sold Out | 0 | $0.00 |
| Q2 2023 | -7,700 | Reduce 89.53% | 900 | $0.24 |
| Q1 2023 | +8,600 | New Buy | 8,600 | $0.24 |
| Q4 2022 | -1,200 | Sold Out | 0 | $0.00 |
| Q3 2022 | +1,200 | New Buy | 1,200 | $223.33 |
| Q2 2021 | -5,300 | Sold Out | 0 | $0.00 |
| Q1 2021 | +5,300 | New Buy | 5,300 | $228.68 |
| Q3 2020 | -5,200 | Sold Out | 0 | $0.00 |
| Q2 2020 | +5,200 | New Buy | 5,200 | $192.69 |
| Q1 2020 | -4,200 | Sold Out | 0 | $0.00 |
| Q4 2019 | +4,200 | New Buy | 4,200 | $191.67 |
| Q3 2019 | -2,300 | Sold Out | 0 | $0.00 |
| Q2 2019 | -5,600 | Reduce 70.89% | 2,300 | $173.91 |
| Q1 2019 | +7,900 | New Buy | 7,900 | $172.53 |
| Q2 2018 | -1,700 | Sold Out | 0 | $0.00 |
| Q1 2018 | +1,700 | New Buy | 1,700 | $153.53 |
Renaissance Technologies (RenTech)'s Vanguard Health Care ETF Investment FAQs
Renaissance Technologies (RenTech) first purchased Vanguard Health Care ETF (VHT) in Q1 2018, acquiring 1,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Vanguard Health Care ETF (VHT) for 24 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Vanguard Health Care ETF (VHT) was in Q2 2025, adding 10,300 shares worth $2.56 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 13,560 shares of Vanguard Health Care ETF (VHT), valued at approximately $3.9 M.
As of the Q4 2025 filing, Vanguard Health Care ETF (VHT) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Vanguard Health Care ETF (VHT) was 13,560 shares, as reported at the end of Q4 2025.